{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:27:14Z","timestamp":1794306434471,"version":"4.9.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently described autoimmune inflammatory disorder of the central nervous system (CNS). There is limited data on the association between Human Immunodeficiency virus (HIV) infection and MOGAD. We report three patients with HIV infection and myelin oligodendrocyte glycoprotein (MOG) antibodies in the setting of other central nervous system infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case descriptions<\/jats:title><jats:p>The first patient, a 44-year-old black African man, presented with acute disseminated encephalomyelitis (ADEM) with positive serum MOG antibodies. He made a significant recovery with corticosteroids but had a quick relapse and died from sepsis. The second patient, an 18-year-old black woman, presented with paraplegia and imaging revealed a longitudinally extensive transverse myelitis and had positive serum MOG antibodies. She remained paraplegic after methylprednisone and plasmapheresis treatments. Her rehabilitation was complicated by development of pulmonary embolism and tuberculosis. The third patient, a 43-year-old mixed-race woman, presented with bilateral painless visual loss. Her investigations were notable for positive MOG antibodies, positive Varicella Zoster Virus on cerebral spinal fluid (CSF) and hyperintense optic nerves on magnetic resonance imaging (MRI). Her vision did not improve with immunosuppression and eventually died from sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our cases illustrate the diagnostic and management challenges of MOGAD in the setting of advanced HIV infection, where the risk of CNS opportunistic infections is high even without the use of immunosuppression. The atypical clinical progression and the dilemmas in the diagnosis and treatment of these cases highlight gaps in the current knowledge of MOGAD among people with HIV that need further exploration.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-023-04191-7","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:02:03Z","timestamp":1697500923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-5511","authenticated-orcid":false,"given":"Yohane","family":"Gadama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e9","family":"Du Preez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarel","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Albertyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ssebambulidde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Brey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franclo","family":"Henning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"4191_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11737-8","author":"A Al-Ani","year":"2023","unstructured":"Al-Ani A, Chen JJ, Costello F. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges. J Neurol. 2023. https:\/\/doi.org\/10.1007\/s00415-023-11737-8.","journal-title":"J Neurol"},{"issue":"22","key":"4191_CR2","first-page":"1","volume":"4422","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;4422(22):1\u201315.","journal-title":"Lancet Neurol"},{"issue":"3","key":"4191_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/jnnp-2020-324323","volume":"92","author":"I Kleerekooper","year":"2021","unstructured":"Kleerekooper I, Trip SA, Plant GT, Petzold A. Expanding the phenotype of MOG antibody-associated disease (MOGAD): half a century of epilepsy and relapsing optic neuritis. J Neurol Neurosurg Psychiatry. 2021;92(3):340\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"4191_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/practneurol-2017-001787","volume":"19","author":"M Jury\u0144czyk","year":"2019","unstructured":"Jury\u0144czyk M, Jacob A, Fujihara K, Palace J. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations. Pract Neurol. 2019;19(3):187\u201395.","journal-title":"Pract Neurol"},{"issue":"12","key":"4191_CR5","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128\u201338.","journal-title":"Brain"},{"issue":"25","key":"4191_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","volume":"2018","author":"R Narayan","year":"2018","unstructured":"Narayan R, Simpson A, Fritsche K, et al. MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2018;2018(25):66\u201372. https:\/\/doi.org\/10.1016\/j.msard.2018.07.025.","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"4191_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/1352458520933884","volume":"27","author":"A Kunchok","year":"2021","unstructured":"Kunchok A, Flanagan EP, Snyder M, et al. Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD. Mult Scler J. 2021;27(4):630\u20135.","journal-title":"Mult Scler J"},{"issue":"1","key":"4191_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12883-017-0858-6","volume":"17","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Nakajima H, Tani H, et al. Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report. BMC Neurol. 2017;17(1):6\u20139.","journal-title":"BMC Neurol"},{"issue":"12","key":"4191_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1177\/0883073817724927","volume":"32","author":"JP Vieira","year":"2017","unstructured":"Vieira JP, Sequeira J, Brito MJ. Postinfectious anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis and myelitis. J Child Neurol. 2017;32(12):996\u20139.","journal-title":"J Child Neurol"},{"key":"4191_CR10","unstructured":"Ann Clin Transl Neurol-2022-Johnsson-SARS\u2010COV\u20102 a trigger of myelin oligodendrocyte glycoprotein\u2010associated disorder.pdf. [date unknown]."},{"key":"4191_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2021.08.001","volume":"124","author":"KC Cay-Martinez","year":"2021","unstructured":"Cay-Martinez KC, Shen MY, Silver WG, Vargas WS. Postinfectious encephalomyelitis associated with myelin oligodendrocyte glycoprotein antibody in a pediatric patient with COVID-19. Pediatr Neurol. 2021;124:40\u20131.","journal-title":"Pediatr Neurol"},{"key":"4191_CR12","doi-asserted-by":"crossref","unstructured":"Hor J, Kazuo Fujihara. Epidemiology of MOGAD: a review of prevalence and incidence worldwide. Front Neurol. 2023;14.","DOI":"10.3389\/fneur.2023.1260358"},{"key":"4191_CR13","unstructured":"Euroimmun. Strategy for determination of autoantibodies against cell nuclei (ANA) and cytoplasm components. 2021."},{"issue":"January","key":"4191_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102753","volume":"49","author":"AA Mbonde","year":"2021","unstructured":"Mbonde AA, Arca KN, Grill MF. Anti-MOG antibody associated encephalomyelitis in an HIV-infected patient. Mult Scler Relat Disord. 2021;49(January): 102753. https:\/\/doi.org\/10.1016\/j.msard.2021.102753.","journal-title":"Mult Scler Relat Disord."},{"key":"4191_CR15","doi-asserted-by":"crossref","unstructured":"Sami Kaldawi, Ranade T, Ashary Z. MOG antibody myelitis following HIV seroconversion (P9-1.002). Neurology 2022;98(18 supplement). Available from: https:\/\/n.neurology.org\/content\/98\/18_Supplement\/2571","DOI":"10.1212\/WNL.98.18_supplement.2571"},{"issue":"6","key":"4191_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibodypositive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014;82(6):474\u201381.","journal-title":"Neurology"},{"issue":"1","key":"4191_CR17","first-page":"1","volume":"5","author":"C Satukijchai","year":"2021","unstructured":"Satukijchai C, Mariano R, Messina S, et al. Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody-associated disease in the United Kingdom. JAMA Netw Open. 2021;5(1):1\u201314.","journal-title":"JAMA Netw Open"},{"key":"4191_CR18","doi-asserted-by":"crossref","unstructured":"Huda S, Whittam D, Jackson R, et al. Predictors of relapse in MOG antibody associated disease: a cohort study. BMJ Open 2021;11(11)","DOI":"10.1136\/bmjopen-2021-055392"},{"issue":"9729","key":"4191_CR19","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/S0140-6736(10)60359-5","volume":"375","author":"RS Wallis","year":"2010","unstructured":"Wallis RS, Pai M, Menzies D, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010;375(9729):1920\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(10)60359-5.","journal-title":"Lancet"},{"key":"4191_CR20","doi-asserted-by":"crossref","unstructured":"Yong YK, Tan HY, Saeidi A, et al. Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects. Front Microbiol. 2019;10(December).","DOI":"10.3389\/fmicb.2019.02789"},{"issue":"11","key":"4191_CR21","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.9734\/BJMMR\/2015\/14259","volume":"5","author":"J Duda","year":"2015","unstructured":"Duda J, Castro J. Bilateral retrobulbar optic neuritis caused by varicella zoster virus in a patient with AIDS. Br J Med Med Res. 2015;5(11):1381\u20136.","journal-title":"Br J Med Med Res"},{"key":"4191_CR22","doi-asserted-by":"crossref","unstructured":"Pauli FD, Morschewsky P, Berek K, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease and varicella zoster virus infection\u2014frequency of an association. 2021;12(October):1\u20139.","DOI":"10.3389\/fimmu.2021.769653"},{"issue":"1","key":"4191_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/sajhivmed.v18i1.684","volume":"18","author":"AI Bhigjee","year":"2017","unstructured":"Bhigjee AI, Moodley AA, Roos I, et al. The neuromyelitis optica presentation and the aquaporin-4 antibody in HIV-seropositive and seronegative patients in KwaZulu-Natal, South Africa. S Afr J HIV Med. 2017;18(1):1\u20137.","journal-title":"S Afr J HIV Med"},{"issue":"1","key":"4191_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s13365-016-0481-0","volume":"23","author":"A Naidoo","year":"2017","unstructured":"Naidoo A, Paruk H, Bhagwan B, Moodley A. Atypical presentations of acute disseminated encephalomyelitis (ADEM) in HIV infection. J Neurovirol. 2017;23(1):160\u201370.","journal-title":"J Neurovirol"},{"key":"4191_CR25","first-page":"1","volume":"2020","author":"P Mart\u00ednez-Ayala","year":"2020","unstructured":"Mart\u00ednez-Ayala P, Valle-Murillo MA, Ch\u00e1vez-Barba O, et al. Acute disseminated encephalomyelitis: an unusual presentation of human immunodeficiency virus infection. Case Rep Infect Dis. 2020;2020:1\u20135.","journal-title":"Case Rep Infect Dis"},{"issue":"5","key":"4191_CR26","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/brain\/awaa102","volume":"143","author":"Y Takai","year":"2020","unstructured":"Takai Y, Misu T, Kaneko K, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 2020;143(5):1431\u201346.","journal-title":"Brain"},{"issue":"MAY","key":"4191_CR27","first-page":"1","volume":"8","author":"P Peschl","year":"2017","unstructured":"Peschl P, Bradl M, H\u00f6ftberger R, et al. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol. 2017;8(MAY):1\u201315.","journal-title":"Front Immunol"},{"issue":"June","key":"4191_CR28","first-page":"1","volume":"13","author":"GS Manzano","year":"2022","unstructured":"Manzano GS, Salky R, Mateen FJ, et al. Positive predictive value of MOG-IgG for clinically defined MOG-AD within a real-world cohort. Front Neurol. 2022;13(June):1\u20134.","journal-title":"Front Neurol"},{"key":"4191_CR29","unstructured":"Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. [date unknown]."},{"key":"4191_CR30","doi-asserted-by":"crossref","unstructured":"Rostaing L, Malvezzi P. Steroid-based therapy and risk of infectious complications. PLoS Med. 2016;13(5).","DOI":"10.1371\/journal.pmed.1002025"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04191-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04191-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04191-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T00:03:35Z","timestamp":1703376215000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04191-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4191"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04191-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained ethical approval to publish the cases from the Stellenbosch University Health Research Ethics Committee (Reference No: C22\/10\/036) after obtaining written informed consent from the patients (and next of kin in the case of the first patient).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients (and next of kin) for publication of this case report and any accompanying images. A copy of the written consent and ethics approval is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they do not have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}